Prestige Consumer Healthcare Inc. (PBH) is a Healthcare stock trading at $51.33 (as of 2026-08-21), with a market capitalization of $2.43B and a trailing P/E of 14.1. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.
Prestige Consumer Healthcare Inc. develops, manufactures, markets, distributes, and sells over-the-counter health and personal care products through two segments: North American OTC Healthcare and International OTC Healthcare. Its products are sold in the United States and internationally through retailers such as mass merchandisers and drug, food, dollar, convenience, and club stores, as well as e-commerce channels.
Prestige Consumer Healthcare develops, manufactures, markets, and sells over-the-counter health and personal care products, making money from brand product sales in North America and internationally across two reportable segments.
Profit is driven by how much it sells of its OTC brand products across its North American and International channels, with the North American OTC business being the larger revenue driver.
| North America OTC | $0.2B |
| International OTC | $0.1B |
Business quality (Solid): Good clarity on product category and two-segment revenue structure, but limited operating KPIs beyond segment revenue in the provided facts.
Valuation: At 13× earnings, PBH trades 25% below the Pharmaceutical Products average (17×). Note: one-time items can distort reported P/E.
| Price | $51.33 |
| Market Cap | $2.43B |
| P/E Ratio | 14.1 |
| EV / EBITDA | 13.5 |
| Price / Book | 1.27 |
| Price / Sales | 2.20 |
| FCF Yield | 9.7% |
| DCF Value (model) | $50.94 |
| DCF Upside vs Price | -0.8% |
| Revenue (TTM) | $1.09B |
| Net Margin | 17.5% |
| Revenue Growth (YoY) | 6.5% |
| EPS Growth (YoY) | -36.5% |
| FCF Growth (YoY) | -14.2% |
| Altman Z-Score | 2.32 (grey) |
| Piotroski F-Score | 5/9 (moderate) |
| Stock P/E | 14.1 |
| Sector P/E (Healthcare) | 21.7 |
| Industry P/E (Pharmaceutical Products) | 17.2 |
| vs Sector | -35.0% |
| vs Industry | -17.7% |
| Top Institutional Holder | BlackRock, Inc. ($437.92M) |
| Institutional Holders Tracked | 10 |
| Sector | Healthcare |
| Industry | Pharmaceutical Products |
| CEO | Ronald Lombardi |
| Employees | 600 |
| Country | US |
| IPO Date | 2005-02-10 |
Data as of 2026-08-21.
Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.